MSB 3.33% $1.40 mesoblast limited

Ann: FDA Grants Orphan Drug Designation for Revascor, page-135

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 243 Posts.
    lightbulb Created with Sketch. 45
    How did your investment in MEM go? Looks like a very high risk stock, did you do any DD there first?

    Must be hard losing so much money, did someone point that out to you on a daily basis on the forums over there? Did someone tell you constantly how risky it was? Seems like a really bad investment in hindsight, can't believe you didn't see that coming, guess you were spending too much time on stocks you don't hold.

    Don't get me wrong, I like having both sides of the story in the forums, but people who are rubbing in the losses of others are just evil. So are people who are condescending and smug when its easy to make remarks in hindsight.

    I was up until the last CR, and I think we all felt that it was more than likely to get a positive outcome. But here we are, and there are enough positive reasons for me to keep my money invested. Selling to me at this point would just be dumb.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.